
11 - 50 employees
Founded 2024
🧬 Biotechnology
💊 Pharmaceuticals
💰 $300M Venture Round - GondolaBio on 2024-08
Biotechnology • Pharmaceuticals
GondolaBio is a clinical-stage biopharmaceutical company launched in 2024 and affiliated with BridgeBio Pharma, focused on developing breakthrough therapeutics for patients with genetic diseases. The company uses a lean, decentralized approach to accelerate early-stage research and development across multiple modalities (including small molecules and oligonucleotide therapies) and is building a diverse pipeline targeting rare and underserved genetic conditions such as EPP/XLP with its lead program PORT-77. GondolaBio centers patient needs and aims to bring disease-modifying treatments more quickly to populations lacking approved therapies.
🕒 March 18
Improve your chances of getting an interview by checking your resume score before you apply.

11 - 50 employees
Founded 2024
🧬 Biotechnology
💊 Pharmaceuticals
💰 $300M Venture Round - GondolaBio on 2024-08
Biotechnology • Pharmaceuticals
GondolaBio is a clinical-stage biopharmaceutical company launched in 2024 and affiliated with BridgeBio Pharma, focused on developing breakthrough therapeutics for patients with genetic diseases. The company uses a lean, decentralized approach to accelerate early-stage research and development across multiple modalities (including small molecules and oligonucleotide therapies) and is building a diverse pipeline targeting rare and underserved genetic conditions such as EPP/XLP with its lead program PORT-77. GondolaBio centers patient needs and aims to bring disease-modifying treatments more quickly to populations lacking approved therapies.
• Design scientifically rigorous, innovative, and cost-effective clinical development programs, integrating preclinical, translational, and biomarker strategies • Direct and oversee the efficient implementation of all clinical projects, including defining initial clinical endpoints, dose-escalation strategies, and patient selection approaches • Lead development and contribute to review of Clinical Study Protocols, Clinical Study Reports, Investigator’s Brochures, and all clinical documentation for regulatory filings • Become an internal expert on all medical features of the disease area, including natural history, patient diagnostic journey, standards of care, and current development programs. • Build, mentor, and scale the clinical development and clinical operations teams, including defining structure, capabilities, and external partnerships appropriate for each stage of the program • Provide leadership and clinical development expertise to the overall organization, including the clinical development, clinical operations, biometrics, toxicology, and translational science teams • Collaborate with Regulatory Affairs to develop strategies and tactical work plans during clinical development and in preparation for the anticipated US and global filings • Lead the preparation and management of clinical information to support timely regulatory submissions, including INDs, briefing documents, and early clinical protocols • Set a high standard and example of urgency, work quality, and effectiveness • Contribute to due diligence and gap analysis on potential new GondolaBio assets • Partner closely with discovery and preclinical teams to ensure clinical readiness for first-in-human studies. • Perform all other duties as assigned
• Doctorate Degree in Medicine (MD) is required for the position • A proven leader with minimum of 10 years pharmaceutical/biotechnology industry experience in all phases of drug development • Deep knowledge of the drug development process with a focus on clinical study design and management; ability to collaborate with, support, and oversee CROs • Able to drive strategic thinking and plans for successful clinical trial outcomes • Experience interfacing with the global regulatory authorities (incl. FDA, EMA) and respective standards, including hands-on experience in global drug development • Recent experience of IND and NDA/BLA submissions strongly preferred • Dynamic individual with excellent written, communication, and interpersonal skills • Ability to deliver effective presentations both internally and externally, and strong networking abilities and creativity • Ability to set priorities, work independently and deliver high-quality results with urgency • Vital planning, organizational, and leadership skills • Results-oriented. Strong initiative, accountability, and willingness to take ownership and drive projects to completion • Experience in driving collaborations and working with external partners, including building networks with key opinion leaders (KOL) and investigators, business partners • Proven ability to build, mentor, and scale clinical development teams over time • Able to proactively identify and solve problems under pressure • Motivated to work in a fast-paced, highly accountable, small company environment. A "can do" and collegial professional who leads through influence and interpersonal skills. • Demonstrated matrix leadership skills and ability to collaborate successfully with multiple functions and external vendors in a cross-functional team environment. • Solid critical, strategic, and analytical thinking skills • Travel required
• Patient Days, where we are fortunate enough to learn more about the lives we are looking to impact and a real exchange of ideas as to how we can improve our efforts • A culture inspired by our values: put patients first; think independently; be radically transparent; every minute counts; and let the science speak • Collaborative business environment • Excellent compensation package (Base, Performance Bonus, Equity) • Excellent benefits package • Flexible PTO • A fast-paced, data-driven, work environment with world-class R&D minds and capabilities • Work with the most productive groups of R&D operators in the industry • A platform for meaningful scientific contributions to shine
Apply Now🕒 March 18
VP of Clinical Development at Tonix Pharmaceuticals, leading clinical trials and strategy for infectious disease. Responsible for regulatory interactions and product approvals with a focus on innovation and operational excellence.
🕒 March 18
Director of Transmission Line Engineering managing complex engineering projects in solar and energy storage at ANS. Leading the engineering team and collaborating with stakeholders for successful project execution.
🕒 March 17
VP of Strategic Alliances leading and executing EDB's Strategic Alliances strategy. Building relationships with global technology leaders to drive growth in data and AI solutions.
🕒 March 16
Vice President of Self-Serve leading growth from API to multi-product voice AI platform. Driving self-serve revenue and user experience at Deepgram.
🇺🇸 United States – Remote
💰 $47M Series B on 2022-11
⏰ Full Time
🔴 Lead
👔 Vice President
🦅 H1B Visa Sponsor
🕒 March 14
Vice President, Clinical Strategy leading clinical operations programs for BlueRidge Life Sciences. Overseeing execution of clinical trials, budgets and fostering collaboration among teams.
🇺🇸 United States – Remote
💰 Venture Round - ToxStrategies on 2023-01
⏰ Full Time
🔴 Lead
👔 Vice President